BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26520782)

  • 21. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.
    Ferreira VM; Piechnik SK; Dall'Armellina E; Karamitsos TD; Francis JM; Ntusi N; Holloway C; Choudhury RP; Kardos A; Robson MD; Friedrich MG; Neubauer S
    J Cardiovasc Magn Reson; 2014 May; 16(1):36. PubMed ID: 24886708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients.
    Ide S; Riesenkampff E; Chiasson DA; Dipchand AI; Kantor PF; Chaturvedi RR; Yoo SJ; Grosse-Wortmann L
    J Cardiovasc Magn Reson; 2017 Feb; 19(1):10. PubMed ID: 28143545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis--a clinical study using myocardial T1-mapping and extracellular volume quantification.
    Ntusi NA; Piechnik SK; Francis JM; Ferreira VM; Rai AB; Matthews PM; Robson MD; Moon J; Wordsworth PB; Neubauer S; Karamitsos TD
    J Cardiovasc Magn Reson; 2014 Mar; 16(1):21. PubMed ID: 24593856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative T1 Mapping for Detecting Microvascular Obstruction in Reperfused Acute Myocardial Infarction: Comparison with Late Gadolinium Enhancement Imaging.
    Shin JM; Choi EY; Park CH; Han K; Kim TH
    Korean J Radiol; 2020 Aug; 21(8):978-986. PubMed ID: 32677382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging.
    Huang L; Zhao P; Tang D; Zhu T; Han R; Zhan C; Liu W; Zeng H; Tao Q; Xia L
    JACC Cardiovasc Imaging; 2020 Nov; 13(11):2330-2339. PubMed ID: 32763118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy.
    Aquaro GD; Positano V; Pingitore A; Strata E; Di Bella G; Formisano F; Spirito P; Lombardi M
    J Cardiovasc Magn Reson; 2010 Apr; 12(1):21. PubMed ID: 20374627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'Image-navigated 3-dimensional late gadolinium enhancement cardiovascular magnetic resonance imaging: feasibility and initial clinical results'.
    Bratis K; Henningsson M; Grigoratos C; Dell'Omodarme M; Chasapides K; Botnar R; Nagel E
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):97. PubMed ID: 29202776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic late gadolinium enhancement cardiac magnetic resonance for diagnosing myocardial scar.
    Abdula G; Nickander J; Sörensson P; Lundin M; Kellman P; Sigfridsson A; Ugander M
    Scand Cardiovasc J; 2018 Jun; 52(3):127-132. PubMed ID: 29544374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of acute myocarditis by cardiovascular MR: diagnostic performance of shortened protocols.
    Chu GC; Flewitt JA; Mikami Y; Vermes E; Friedrich MG
    Int J Cardiovasc Imaging; 2013 Jun; 29(5):1077-83. PubMed ID: 23404383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis.
    Giollo A; Dumitru RB; Swoboda PP; Plein S; Greenwood JP; Buch MH; Andrews J
    Int J Cardiovasc Imaging; 2021 Mar; 37(3):1053-1062. PubMed ID: 33057879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of both the area-at-risk and acute myocardial infarct size in ST-segment elevation myocardial infarction using T1-mapping.
    Bulluck H; Hammond-Haley M; Fontana M; Knight DS; Sirker A; Herrey AS; Manisty C; Kellman P; Moon JC; Hausenloy DJ
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):57. PubMed ID: 28764773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of fully automated myocardial segmentation techniques in native and contrast-enhanced T1-mapping cardiovascular magnetic resonance images using fully convolutional neural networks.
    Farrag NA; Lochbihler A; White JA; Ukwatta E
    Med Phys; 2021 Jan; 48(1):215-226. PubMed ID: 33131085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping.
    Liang YD; Xu YW; Li WH; Wan K; Sun JY; Lin JY; Zhang Q; Zhou XY; Chen YC
    J Cardiovasc Magn Reson; 2020 Jan; 22(1):2. PubMed ID: 31902370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial late gadolinium enhancement using delayed 3D IR-FLASH in the pediatric population: feasibility and diagnostic performance compared to single-shot PSIR-bSSFP.
    Saprungruang A; Aguet J; Gill N; Tassos VP; Amirabadi A; Seed M; Yoo SJ; Lam CZ
    J Cardiovasc Magn Reson; 2023 Jan; 25(1):2. PubMed ID: 36683053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease.
    Ngu PJ; Butler M; Pham A; Roberts SK; Taylor AJ
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):629-36. PubMed ID: 26667447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T
    Zhu Y; Yang D; Zou L; Chen Y; Liu X; Chung YC
    J Cardiovasc Magn Reson; 2019 Nov; 21(1):72. PubMed ID: 31752919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of cine CMR imaging at 0.55 T and 1.5 T.
    Bandettini WP; Shanbhag SM; Mancini C; McGuirt DR; Kellman P; Xue H; Henry JL; Lowery M; Thein SL; Chen MY; Campbell-Washburn AE
    J Cardiovasc Magn Reson; 2020 May; 22(1):37. PubMed ID: 32423456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.
    Swoboda PP; McDiarmid AK; Erhayiem B; Law GR; Garg P; Broadbent DA; Ripley DP; Musa TA; Dobson LE; Foley JR; Fent GJ; Page SP; Greenwood JP; Plein S
    J Cardiovasc Magn Reson; 2017 Feb; 19(1):16. PubMed ID: 28215181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.